Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Breast Cancer Res Treat. 2016 Mar 26;156(3):415–426. doi: 10.1007/s10549-016-3765-4

Table 3.

Comparisons of outcomes between different pharmacologic treatments

Reference Interventions Hot flashes Mood Quality
of life
Patient
preference
Blood
Pressure
Additional
side effectsa
Time to hot flash
improvement
Boekhout et al. [33] Venlafaxine 75 mg or clonidine 0.1 mg daily Clonidine: ↑ anxiety
Venlafaxine: ↑ depression
N/A Venlafaxine: ↓ appetite Favors venlafaxine (effect in 1-2 weeks) over clonidine (>4 weeks)
Bordeleau et al. [34] Venlafaxine 75 mg or gabapentin 900 mg daily Venlafaxine (vs. gabapentin): ↓ negative mood Venlafaxine preferred N/A Venlafaxine: ↓ appetite, ↑nausea and constipation
Gabapentin: ↑dizziness, ↑appetite
Buijs et al. [35] Venlafaxine 75 mg or clonidine 0.1 mg daily Venlafaxine: ↓ depression Clonidine: ↓ 5 mmHg systolic
↓ 3 mmHg diastolic
Venlafaxine: ↓appetite, ↑nausea and constipation, ↑study withdrawal
Clonidine: ↑pain, ↑itching
Loibl et al. [36] Venlafaxine 75 mg daily or clonidine 0.15 mg daily Favors venlafaxine N/A N/A N/A N/A Venlafaxine: ↑nausea Favors venlafaxine

↔ no difference among groups, ↑ increased, ↓, decreased, N/A not assessed

a

Only outcomes that were statistically significantly different among hot flash treatment groups are presented